Arcellx, Inc. ( ACLX) - Key Metrics
Stock symbol ACLX is outdated, potentially delisted? Maybe it is available on other exchange?
ACLX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | $0.03 | -$1.03 | -$1.03 | -$1.05 |
| 2025Q3 | $0.09 | -$0.99 | -$0.87 | -$0.87 |
| 2025Q2 | $0.13 | -$0.94 | -$0.71 | -$0.72 |
| 2025Q1 | $0.15 | -$1.13 | -$1.14 | -$1.16 |
| 2024Q4 | $0.28 | -$0.88 | -$0.86 | -$0.89 |
ACLX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | ? | -15.79 |
| 2025Q3 | ? | -20.82 |
| 2025Q2 | ? | -17.54 |
| 2025Q1 | ? | -14.55 |
| 2024Q4 | ? | -21.87 |
ACLX
Price: $115.07
52 week price:
Earnings Per Share: -4.07 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 6.7 billion